Clinical trial · Observational
Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.
Oxidative Stress and Inflammatory Processes in Selected Neoplasms in the Group of Oncological Patients Examined With the FDG PET/CT Method.
NCT03470857CI-TRIAL-00061109completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The research aims to determine the parameters of oxidative stress and inflammatory processes and compare these parameters with the image obtained using positron emission tomography (PET) with 2-deoxy-2-\[fluorine-18\]fluoro- D-glucose (18F-FDG) integrated with computed tomography (CT) in the group of oncological patients.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Antioxidants | — | UNRESOLVED | — |
| Inflammation | — | UNRESOLVED | — |
| Lipid Peroxidation | — | UNRESOLVED | — |
| Lysosome Alteration | — | UNRESOLVED | — |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Oxidative Stress | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patients | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients
- description
- Oncological patients: lymphomas (Hodgkin's, DLBCL), breast and ovarian cancers, brain gliomas.
- interventionNames
- Diagnostic Test: Patients
- label
- Control
- description
- The number at most half as large as the patients' group, composed of healthy people at similar age and the same sex as patients.
Primary outcomes (13)
- measure
- Superoxide Dismutase
- timeFrame
- 1 day (Single measurement)
- description
- Antioxidant enzyme
- measure
- Catalase
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: \- sign informed consent form for participation in the study Exclusion Criteria: * other diseases, * bad feeling of the studied individual on the day of the study, * the participants will not be minor and incapacitated persons, soldiers, prisoners and persons dependent in any way from the investigators.
References
Publications (0)
Data not yet available
No reference posted for this study.